Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum
- PMID: 25650007
- DOI: 10.1111/jnc.13049
Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum
Abstract
Positive allosteric modulation of α7 isoform of nicotinic acetylcholine receptors (α7-nAChRs) is emerging as a promising therapeutic approach for central nervous system disorders such as schizophrenia or Alzheimer's disease. However, its effect on Ca(2+) signaling and cell viability remains controversial. This study focuses on how the type II positive allosteric modulator (PAM II) PNU120596 affects intracellular Ca(2+) signaling and cell viability. We used human SH-SY5Y neuroblastoma cells overexpressing α7-nAChRs (α7-SH) and their control (C-SH). We monitored cytoplasmic and endoplasmic reticulum (ER) Ca(2+) with Fura-2 and the genetically encoded cameleon targeting the ER, respectively. Nicotinic inward currents were measured using patch-clamp techniques. Viability was assessed using methylthiazolyl blue tetrazolium bromide or propidium iodide staining. We observed that in the presence of a nicotinic agonist, PNU120596 (i) reduced viability of α7-SH but not of C-SH cells; (ii) significantly increased inward nicotinic currents and cytosolic Ca(2+) concentration; (iii) released Ca(2+) from the ER by a Ca(2+) -induced Ca(2+) release mechanism only in α7-SH cells; (iv) was cytotoxic in rat organotypic hippocampal slice cultures; and, lastly, all these effects were prevented by selective blockade of α7-nAChRs, ryanodine receptors, or IP3 receptors. In conclusion, positive allosteric modulation of α7-nAChRs with the PAM II PNU120596 can lead to dysregulation of ER Ca(2+) , overloading of intracellular Ca(2+) , and neuronal cell death. This study focuses on how the type II positive allosteric modulator PNU120596 (PAM II PNU12) affects intracellular Ca(2+) signaling and cell viability. Using SH-SY5Y neuroblastoma cells overexpressing α7-nAChRs (α7-SH) and their control (C-SH), we find that PAM of α7-nAChRs with PNU120596: (i) increases inward calcium current (ICa ) and cytosolic Ca(2+) concentration ([Ca(2+) ]cyt ); (ii) releases Ca(2+) from the ER ([Ca(2+) ]ER ) by a Ca(2+) -induced Ca(2+) release mechanism; and (iv) reduces cell viability. These findings were corroborated in rat hippocampal organotypic cultures. [Ca(2+) ]cyt , cytosolic Ca(2+) concentration; [Ca(2+) ]ER , endoplasmic reticulum Ca(2+) concentration; α7 nAChR, α7 isoform of nicotinic acetylcholine receptors; α7-SH, SH-SY5Y stably overexpressing α7 nAChRs cells; C-SH, control SH-SY5Y cells; Nic, nicotine; PNU12, PNU120596.
Keywords: Ca2+; D1-ER cameleon probe; cytotoxicity; positive allosteric modulators; α7 nicotinic receptors.
© 2015 International Society for Neurochemistry.
Comment in
-
Are positive allosteric modulators of α7 nAChRs clinically safe?J Neurochem. 2016 Jan;136(2):217-9. doi: 10.1111/jnc.13236. Epub 2015 Sep 8. J Neurochem. 2016. PMID: 26182952 No abstract available.
Similar articles
-
Local and global calcium signals associated with the opening of neuronal alpha7 nicotinic acetylcholine receptors.Cell Calcium. 2009 Feb;45(2):198-207. doi: 10.1016/j.ceca.2008.10.003. Epub 2008 Nov 26. Cell Calcium. 2009. PMID: 19038445
-
Functional properties of alpha7 nicotinic acetylcholine receptors co-expressed with RIC-3 in a stable recombinant CHO-K1 cell line.Assay Drug Dev Technol. 2008 Apr;6(2):181-93. doi: 10.1089/adt.2007.120. Assay Drug Dev Technol. 2008. PMID: 18471073
-
Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.Mol Pharmacol. 2007 Sep;72(3):715-24. doi: 10.1124/mol.107.035410. Epub 2007 Jun 12. Mol Pharmacol. 2007. PMID: 17565004
-
α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.Adv Exp Med Biol. 2012;740:603-38. doi: 10.1007/978-94-007-2888-2_27. Adv Exp Med Biol. 2012. PMID: 22453962 Free PMC article. Review.
-
Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor.Recent Pat CNS Drug Discov. 2007 Jun;2(2):99-106. doi: 10.2174/157488907780832751. Recent Pat CNS Drug Discov. 2007. PMID: 18221220 Review.
Cited by
-
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer's Disease.Cells. 2020 Dec 10;9(12):2655. doi: 10.3390/cells9122655. Cells. 2020. PMID: 33321866 Free PMC article. Review.
-
The Antinociceptive and Anti-Inflammatory Properties of the α7 nAChR Weak Partial Agonist p-CF3 N,N-diethyl-N'-phenylpiperazine.J Pharmacol Exp Ther. 2018 Nov;367(2):203-214. doi: 10.1124/jpet.118.249904. Epub 2018 Aug 15. J Pharmacol Exp Ther. 2018. PMID: 30111636 Free PMC article.
-
Nicotinic acetylcholine receptors: Therapeutic targets for novel ligands to treat pain and inflammation.Pharmacol Res. 2023 Apr;190:106715. doi: 10.1016/j.phrs.2023.106715. Epub 2023 Mar 1. Pharmacol Res. 2023. PMID: 36868367 Free PMC article. Review.
-
Molecular function of α7 nicotinic receptors as drug targets.J Physiol. 2018 May 15;596(10):1847-1861. doi: 10.1113/JP275101. Epub 2017 Nov 29. J Physiol. 2018. PMID: 29131336 Free PMC article. Review.
-
Effects of α7 Nicotinic Receptor Activation on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.Neurotox Res. 2018 May;33(4):887-895. doi: 10.1007/s12640-017-9854-2. Epub 2017 Dec 22. Neurotox Res. 2018. PMID: 29273965
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous